ストックスクリーナーアプリを入手
4.35
4.19%
-0.19
アフターアワーズ：
4.40
0.05
+1.15%
前日終値:
$4.54
開ける：
$4.54
24時間の取引高:
751.73K
Relative Volume:
3.58
時価総額：
$46.98M
収益：
-
当期純損益:
$-19.25M
株価収益率:
-2.4438
EPS:
-1.78
ネットキャッシュフロー:
$-17.87M
1週間 パフォーマンス:
+6.88%
1か月 パフォーマンス:
+6.62%
6か月 パフォーマンス:
+22.88%
1年 パフォーマンス:
+18.53%
1日の値動き範囲:
$4.28
$4.54
1週間の範囲:
$4.00
$4.67
52週間の値動き範囲:
$2.55
$6.118
Lantern Pharma Inc Stock (LTRN) Company Profile
LTRN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
LTRN
Lantern Pharma Inc
|
4.35 | 49.03M | 0 | -19.25M | -17.87M | -1.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Lantern Pharma Inc Stock (LTRN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-10-07 | 開始されました | H.C. Wainwright | Buy |
Lantern Pharma Inc (LTRN) 最新ニュース
FDA Guidance Advances Lantern Pharma's Pediatric Brain Cancer Therapy Toward 2026 Clinical Trial - citybuzz -
Using flow based indicators on Lantern Pharma Inc.July 2025 Summary & Expert Approved Trade Ideas - newser.com
Is Lantern Pharma Inc. stock a buy for dividend growthJuly 2025 Highlights & Entry Point Confirmation Signals - newser.com
What’s the recovery path for long term holders of Lantern Pharma Inc.Market Sentiment Review & Long-Term Growth Plans - newser.com
Lantern Pharma Inc.’s volatility index tracking explained2025 Geopolitical Influence & Reliable Breakout Stock Forecasts - newser.com
Lantern Pharma Inc. stock prediction for this week2025 Growth vs Value & Weekly Market Pulse Updates - newser.com
Two stocks to invest in the future of pharma | 2025-09-29 | Investing News - Stockhouse
Why Lantern Pharma Inc. is moving todayJuly 2025 Technicals & High Accuracy Trade Signal Alerts - newser.com
What analysts say about Lantern Pharma Inc stockRisk Adjusted Returns & Free Unlock Portfolio Growth - earlytimes.in
What drives Lantern Pharma Inc stock priceEconomic Indicators Overview & Small Budget Capital Investment - earlytimes.in
Is Lantern Pharma Inc. showing signs of accumulationJuly 2025 Action & Weekly High Potential Alerts - newser.com
Lantern Pharma Holds Annual Stockholders Meeting - TipRanks
Lantern Pharma shareholders elect directors and approve stock option repricing - Investing.com
Earnings Update: Can LEXX maintain its current growth ratePortfolio Performance Report & High Accuracy Investment Signals - khodrobank.com
Market Fear: Whats the beta of Lantern Pharma Inc stockAnalyst Upgrade & High Accuracy Trade Signal Alerts - khodrobank.com
Pattern recognition hints at Lantern Pharma Inc. upsideMarket Risk Summary & Reliable Intraday Trade Alerts - newser.com
Profit Recap: How liquid is Lantern Pharma Inc. stockQuarterly Profit Report & Long-Term Growth Portfolio Plans - خودرو بانک
Recap Report: Is Cenovus Energy Inc Equity Warrant impacted by rising rates2025 Trade Ideas & Risk Managed Trade Strategies - khodrobank.com
Intraday pattern recognizer results for Lantern Pharma Inc.Market Growth Summary & Breakout Confirmation Alerts - newser.com
How to track smart money flows in Lantern Pharma Inc.Insider Selling & High Yield Stock Recommendations - newser.com
Returns Recap: Will RKDA outperform small cap indexesEarnings Growth Summary & Technical Buy Zone Confirmation - khodrobank.com
Comparing Lantern Pharma Inc. in custom built stock radarsPortfolio Growth Summary & Stepwise Trade Execution Plans - newser.com
Lantern Pharma’s LP-184 Phase 1a Clinical Trial Achieves All Primary Endpoints with Robust Safety Profile and Promising Antitumor Activity in Multiple Advanced Solid Tumors - BioSpace
Using AI based signals to follow Lantern Pharma Inc.Weekly Stock Recap & Weekly High Conviction Trade Ideas - newser.com
Insider Sell: What are Lantern Pharma Incs recent SEC filings showingVolume Spike & Verified Entry Point Signals - khodrobank.com
Aug Spikes: Whats the beta of Lantern Pharma Inc stockEarnings Trend Report & Safe Entry Trade Signal Reports - خودرو بانک
Lantern Pharma (LTRN) Advances LP-184 with Positive Phase 1a Tri - GuruFocus
Lantern Pharma Says Phase 1a Study Of LP-184 Met All Primary Endpoints In Advanced Solid Tumors - Nasdaq
Lantern Pharma stock climbs after LP-184 cancer drug hits trial endpoints - Investing.com Canada
Aug Retail: Can Lantern Pharma Inc disrupt its industryQuarterly Profit Report & Stepwise Swing Trade Plans - خودرو بانک
What to do if you’re stuck in Lantern Pharma Inc.Risk Management & Stepwise Trade Signal Implementation - newser.com
Forecasting Lantern Pharma Inc. price range with options dataWeekly Market Summary & Low Drawdown Investment Ideas - newser.com
Will earnings trigger a reversal in Lantern Pharma Inc.Market Growth Report & Community Trade Idea Sharing - newser.com
RedChip to Host Exclusive Investor Webinar Featuring Lantern Pharma on August 26 - The Marion Star
How to use Fibonacci retracement on Lantern Pharma Inc.Portfolio Risk Summary & Expert Curated Trade Setup Alerts - newser.com
Lantern Pharma (NASDAQ: LTRN) CEO Panna Sharma Featured on IBN’s BioMedWire Podcast - Barchart.com
IBN Announces Latest Episode of The BioMedWire Podcast Featuring Panna Sharma, CEO of AI-Driven Biotech Focused on Challenging & Rare Cancers, Lantern Pharma Inc. (LTRN) - The Manila Times
IBN Announces Latest Episode of The BioMedWire Podcast - GlobeNewswire
Lantern Pharma Inc (LTRN) 財務データ
収益
当期純利益
現金流量
EPS
2.36%
1.10%
大文字化:
|
ボリューム (24 時間):